Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence C Paoletti

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2008
Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switchingHilde-Kari Guttormsen, Lawrence C Paoletti, Keith G Mansfield, et al.
Nature Reviews. Microbiology|November 8, 2006
Group B Streptococcus: global incidence and vaccine developmentAtul Kumar Johri, Lawrence C Paoletti, Philippe Glaser, et al.
The Journal of Infectious Diseases|March 5, 2004
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccinesCarol J Baker, Lawrence C Paoletti, Marcia A Rench, et al.
Journal of Medical Microbiology|May 12, 2006
Identification of novel cps locus polymorphisms in nontypable group B StreptococcusSrinivas V Ramaswamy, Patricia Ferrieri, Lawrence C Madoff, et al.
Infection and Immunity|March 16, 2002
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14Hilde-Kari Guttormsen, Carol J Baker, Moon H Nahm, et al.
Infection and Immunity|January 11, 2007
Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasionAtul K Johri, Immaculada Margarit, Mark Broenstrup, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS IIISharon L Hillier, Patricia Ferrieri, Morven S Edwards, et al.
Science (New York, N.Y.)|July 5, 2005
Identification of a universal Group B streptococcus vaccine by multiple genome screenDomenico Maione, Immaculada Margarit, Cira D Rinaudo, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2008
Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switchingHilde-Kari Guttormsen, Lawrence C Paoletti, Keith G Mansfield, et al.
Nature Reviews. Microbiology|November 8, 2006
Group B Streptococcus: global incidence and vaccine developmentAtul Kumar Johri, Lawrence C Paoletti, Philippe Glaser, et al.
The Journal of Infectious Diseases|March 5, 2004
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccinesCarol J Baker, Lawrence C Paoletti, Marcia A Rench, et al.
Journal of Medical Microbiology|May 12, 2006
Identification of novel cps locus polymorphisms in nontypable group B StreptococcusSrinivas V Ramaswamy, Patricia Ferrieri, Lawrence C Madoff, et al.
Infection and Immunity|March 16, 2002
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14Hilde-Kari Guttormsen, Carol J Baker, Moon H Nahm, et al.
Infection and Immunity|January 11, 2007
Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasionAtul K Johri, Immaculada Margarit, Mark Broenstrup, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2018
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS IIISharon L Hillier, Patricia Ferrieri, Morven S Edwards, et al.
Science (New York, N.Y.)|July 5, 2005
Identification of a universal Group B streptococcus vaccine by multiple genome screenDomenico Maione, Immaculada Margarit, Cira D Rinaudo, et al.
Pageof 3